MARSHALL WACE, LLP: PSEC position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on PSEC, newest first. How the timeline and the estimate are built.
MARSHALL WACE, LLP held 3,067,650 PSEC shares at 2026-06-30 per its 13F-HR filed 2026-08-13.
the latest 13F is the newest step
- period ended2026-06-3013F 3,067,650 sharesChange vs previous 13F -1,683,570 shares
0.01% of the 13F portfolio, value $7,086,270.
13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 4,751,220 sharesChange vs previous 13F -1,462,296 shares
0.01% of the 13F portfolio, value $12,400,682.
13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 6,213,516 sharesChange vs previous 13F -454,860 shares
0.02% of the 13F portfolio, value $16,093,005.
13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 6,668,376 sharesChange vs previous 13F +2,761,351 shares
0.02% of the 13F portfolio, value $18,338,035.
13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 3,907,025 sharesChange vs previous 13F not available
0.01% of the 13F portfolio, value $12,424,340.
13F-HR 0001318757-25-000034 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).